{
  "id": "clinical#screening_cues_42822cb2",
  "content": "333.99 (G25.71) Tardive Akathisia\nTardive syndrome involving other types of movement problems,\nsuch as dystonia or akathisia, which are distinguished by their late\nemergence in the course of treatment and their potential persistence\nfor months to years, even in the face of neuroleptic discontinuation\nor dosage reduction.\nMedication-Induced Postural Tremor\n333.1 (G25.1) Medication-Induced Postural Tremor\nFine tremor (usually in the range of 8–12 Hz) occurring during at-\ntempts to maintain a posture and developing in association with the\nuse of medication (e.g., lithium, antidepressants, valproate). This\ntremor is very similar to the tremor seen with anxiety, caffeine, and\nother stimulants.\nOther Medication-Induced Movement Disorder\n333.99 (G25.79) Other Medication-Induced Movement Disorder\nThis category is for medication-induced movement disorders not\ncaptured by any of the specific disorders listed above. Examples in-\nclude 1) presentations resembling neuroleptic malignant syndrome\nthat are associated with medications other than neuroleptics and\n2)other medication-induced tardive conditions.\nMedication-Induced Movement Disorders 351\nAntidepressant Discontinuation Syndrome\n995.29 (T43.205A) Initial encounter\n995.29 (T43.205D) Subsequent encounter\n995.29 (T43.205S) Sequelae\nAntidepressant discontinuation syndrome is a set of symptoms that can\noccur after an abrupt cessation (or marked reduction in dose) of an anti-",
  "metadata": {
    "source": "DSM-5",
    "url": "https://psychiatry.org/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "study",
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues 333.99 (G25.71) Tardive Akathisia\nTardive syndrome involving other types of movement problems,\nsuch as dystonia or akathisia, which are distinguished by their late\nemergence in the course of treatment and their potential persistence\nfor months to years, even in the face of neuroleptic discontinuation\nor dosage reduction.\nMedication-Induced Postural Tremor\n333.1 (G25.1) Medication-Induced Postural Tremor\nFine tremor (usually in the range of 8–12 Hz) occurring during at-\ntempts to maintain a posture and developing in association with the\nuse of medication (e.g., lithium, antidepressants, valproate). This\ntremor is very similar to the tremor seen with anxiety, caffeine, and\nother stimulants.\nOther Medication-Induced Movement Disorder\n333.99 (G25.79) Other Medication-Induced Movement Disorder\nThis category is for medication-induced movement disorders not\ncaptured by any of the specific disorders listed above. Examples in-\nclude 1) presentations resembling neuroleptic malignant syndrome\nthat are associated with medications other than neuroleptics and\n2)other medication-induced tardive conditions.\nMedication-Induced Movement Disorders 351\nAntidepressant Discontinuation Syndrome\n995.29 (T43.205A) Initial encounter\n995.29 (T43.205D) Subsequent encounter\n995.29 (T43.205S) Sequelae\nAntidepressant discontinuation syndrome is a set of symptoms that can\noccur after an abrupt cessation (or marked reduction in dose) of an anti- 333.99 (g25.71) tardive akathisia\ntardive syndrome involving other types of movement problems,\nsuch as dystonia or akathisia, which are distinguished by their late\nemergence in the course of treatment and their potential..."
}